Project Number EUJPND-FranceANR-DERREUMAUX-633 Agency/Funding Organization Agence Nationale de la Recherche (ANR) Funding Year 2016 View Full Project Details for A new Generation of Drugs for ALzheimer’s disease based on in vitro and in silico experiments of beta-amyloid oligomers and in vivo tests Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator DERREUMAUX, Philippert Principal Investigator First Name Philippert Principal Investigator Last Name DERREUMAUX Awardee Organization LBT Paris Contact PI Country France Project Detail FY Overall Cost $146,232 Funding Organization Agency/Funding Organization Agence Nationale de la Recherche (ANR) Funding Organization Country France Special Initiative EU Joint Programme - Neurodegenerative Disease Research - Research Mapping (2016)
